Linda Palczuk

Chief Executive Officer, Osiris Therapeutics.

Companies

Avadel PharmaceuticalsBoard member Jul 27, 2018 to now¹
Verrica Pharmaceuticals Inc.Chief operating officer Jun 14, 2018 to Mar 4, 2019²
Osiris TherapeuticsChief executive officer Sep 21, 2017 to Sep 21, 2017³
Osiris TherapeuticsPresident Sep 21, 2017 to Sep 21, 2017³

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 12, 2026Returned to company 78,905 shares at $21.00 of Avadel Pharmaceuticals⁴
Jul 29, 2025Granted 11,000 shares of Avadel Pharmaceuticals⁵
Jan 21, 2025Bought 5,000 shares at $7.93 of Avadel Pharmaceuticals⁶
Dec 24, 2024Gift 3,500 shares of Avadel Pharmaceuticals⁷
Dec 6, 2024Bought 3,000 shares at $10.19 of Avadel Pharmaceuticals⁸
Jul 30, 2024Granted 11,000 shares of Avadel Pharmaceuticals⁹
May 9, 2023Bought 2,500 shares at $14.76 of Avadel Pharmaceuticals¹⁰
Dec 23, 2022Bought 2,000 shares at $7.20 of Avadel Pharmaceuticals¹¹
May 27, 2022Bought 10,000 shares at $1.60 of Avadel Pharmaceuticals¹²

The numbers on this page point here. Each one links to the record it came from.